Cargando…
Effects of Long-acting Injectable 3-Monthly Paliperidone Palmitate on the Clinical and Social Performance of Patients with Schizophrenia
OBJECTIVE: To investigate the effects of long-acting injectable 3-monthly paliperidone palmitate on the clinical and social functioning of patients with schizophrenia. METHODS: This study enrolled patients with schizophrenia receiving long-acting injectable 1-monthly paliperidone palmitate for at le...
Autores principales: | Oh, Jihoon, Oh, Jihye, Kim, Dong Wook, Youn, HyunChul, Kim, Sae-Hoon, Kim, Soo In, Chung, In Won, Wang, Kuan Shu, Kim, Minah, Paik, Jong-Woo, Koh, Min Jung, Lee, Yoosun, Choi, Seok Young, Kim, Jung-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889906/ https://www.ncbi.nlm.nih.gov/pubmed/36700319 http://dx.doi.org/10.9758/cpn.2023.21.1.126 |
Ejemplares similares
-
S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020) -
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
por: Mathews, Maju, et al.
Publicado: (2019) -
Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia
por: Bell Lynum, Karimah S., et al.
Publicado: (2018) -
F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY
por: Mathews, Maju, et al.
Publicado: (2018) -
Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
por: Nash, Abigail I, et al.
Publicado: (2019)